《盈警響號》寶勝國際(03813.HK)料首季盈轉虧 蝕1.67億人幣
寶勝國際(03813.HK)發盈警,集團預期今年首季將錄得重大未經審核綜合虧損淨額約1.67億元人民幣(下同),而去年同期為錄溢利淨額2.05億元。淨虧損主要歸因於新型冠狀病毒疫情之爆發及中國政府實施了多項嚴格管制措施,導致於今年2月及3月集團大多數零售店舖及若干辦事處曾暫時關閉。因此,集團該期間之營業收入大幅下跌,而集團之業績亦受到不利影響。
集團指,儘管仍在不斷對抗疫情,由於中國政府已局部撤銷若干管制措施,目前集團超過98%直營零售店舖及加盟店舖已恢復營業。管理層預期消費者開支及集團之業務動力可能需要若干時間才可完全復甦。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.